Zinzino Q2 Revenue Up 18% To SEK 322.40 Million ($37 Million)

The second quarter of 2021 was yet another quarter in which good sales growth was combined with high profitability.
Total revenues in the Group increased by 18% and amounted to SEK 322.4 (274.3) million.
EBITDA result amounted to SEK 33.4 (16.0) million for the quarter and the EBITDA margin amounted to 10.4% (5.8%).
The margin improvement is achieved through economies of scale due to improved efficiency in IT systems, logistics and within the organization. During the quarter, sales started in India, and Malaysia achieved full market status. In addition, the new products BalanceOil+ Premium and ZinzinoGene+ were launched.
The good profitability during the first half of the year means that the board writes up the profit forecast for the full year. The expected EBITDA margin for the full year is now adjusted up from at least 6% to between 8% -11%. The total income for the full year is expected to exceed SEK 1,400 million.
APRIL-JUNE
- Total revenues increased by 18% to SEK 322.4(274.3) million
- Gross profit amounted to SEK 105.1 (73.5) million and the gross profit margin was 32.6% (26.8%)
- EBITDA amounted to SEK 33.4 (16.0) million and the EBITDA margin to 10.4% (5.8%)
- Cash flow from operating activities amounted to SEK 22.4 (19.9) million
- The Board adjusts the expected EBITDA margin for the full year to 8% -11%
JANUARY-JUNE
- Total revenues increased by 27% to SEK 655.8(516.4) million
- Gross profit was SEK 206.3 (157.2*) million and the gross profit margin was 31.5% (30.4%*)
- Adjusted gross profit was SEK 206.3 (135.0*) million and the adjusted gross profit margin was 31.5% (26.1%*)
- EBITDA was SEK 70.7 (42.3*) million and the EBITDA margin was 10.8% (8.2%*)
- Adjusted EBITDA was SEK 70.7 (20.1*) million and the adjusted EBITDA margin was 10.8% (3.9%*)
- Cash flow from operating activities was SEK 70.4 (52.5) million
Cash and cash equivalents at the balance sheet date amounted to SEK 166.9 (107.2) million
* For comparative figures for the first half of 2020 gross profit and EBITDA are affected with SEK 22.2 million due to a change in accounting as a result of changes in distributor remuneration terms.
About Zinzino
Zinzino AB (publ.) is a global Direct Sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS.
Zinzino is based in Gothenburg, with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong and Malaysia. Zinzino is a public company and its shares are listed on Nasdaq First North Premier Growth Market. For more informaton please visit www.zinzino.com
Get more information, facts and figures about Zinzino, click here for the Zinzino overview.
Disclaimer: At BFH, we strive to keep all content—articles, press releases, data—as accurate and current as possible. However, treat this content as a guide, not as definitive authority for business decisions. Publishing a press release does not imply Business For Home BV endorses a company or individual, nor guarantees its claims. No warranties or representations, expressed or implied, are made regarding the accuracy, completeness, or suitability of information provided on this website. All content is provided “as-is,” without liability for errors or usage. Always fact-check and conduct your own due diligence. BFH publishes press releases for the global Direct Selling / Network Marketing / Home Business community. Laws governing Direct Selling can vary greatly by country; BFH does not warrant that any company or content is in full compliance with various local or country-specific laws; it’s up to the reader to research, verify and comply with all applicable local regulations.
Recommended Distributors Zinzino
Cherry Li

Trine Grung
Top earner

Danny Wanzeele

George Robinson

Cecilia Korp

Débora Morais

Marsha Pearson

Elina Carblom

Karla Nelson Wolf

Melanie Blankmann
